BioTime (BTX)

Add to Watchlists
Create an Alert
2.82 -0.06  -2.08% NYSE MKT May 5, 20:00 Delayed 2m USD
View Full Chart
BTX Price Chart
View All Events

BTX Events

Date Type Description
06/06/2016 16:45 CDT Misc Oncocyte’s Bladder Cancer Abstract to Be Featured in a Poster Discussion Session at the 2016 American Society of Clinical Oncology (Asco) Annual Meeting
03/31/2016 16:30 EST Misc BioTime, Inc. To Host Conference Call to Update Investors on Recent Accomplishments and Corporate Objectives for 2016
03/29/2016 16:30 EST Misc BioTime Inc Fourth Quarter Earnings Results in 2016
03/29/2016 Earnings BioTime Inc Fourth Quarter Earnings Results in 2016 Release
01/04/2016 Spinoffs Ratio: 270627:250000
11/09/2015 16:30 EST Misc BioTime Inc Third Quarter Earnings Conference Call in 2015
11/09/2015 Earnings BioTime Inc Third Quarter Earnings in 2015 Release
08/07/2015 Earnings BioTime Inc Second Quarter Earnings in 2015 Release
08/07/2015 Earnings BioTime Inc Second Quarter Earnings in 2015 Release
08/07/2015 Misc BioTime Inc Second Quarter Earnings Conference Call in 2015
View All Performance Charts

BTX Total Returns Comparison

Advertisement

One Page Reports

Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • URL: http://www.biotimeinc.com
  • Investor Relations URL: http://investor.biotimeinc.com/phoenix.zhtml?c=83805&p=irol-IRHome
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: California
  • Est. Current Fiscal Quarter End: June 30, 2016
  • Est. Current Fiscal Year End: December 31, 2016
  • Last Fiscal Quarter End: December 31, 2015
  • Last Fiscal Year End: December 31, 2015
  • Next Earnings Release: N/A
  • NAICS Name: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry Name: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector Name: Manufacturing
  • Profile: BioTime Inc is a biotechnology company. The Company is engaged in the biomedical research and product development in regenerative medicine including human embryonic stem cell and induced pluripotent stem cell technology.

BTX Comparables

Edit

BTX Excel Add-In Codes

  • Name: =YCI("BTX","name")
  • Description: =YCI("BTX","description")
  • Sector: =YCI("BTX","sector")
  • Industry: =YCI("BTX","industry")
  • Est. Current Fiscal Year End: =YCI("BTX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.